ABEONA THERAPEUTICS INC. Shares Outstanding (Cover Page)
ABEONA THERAPEUTICS INC. (ABEO) had Shares Outstanding (Cover Page) of 57.18 million shares as of 2026-08-10, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-10: Entity Common Stock, Shares Outstanding 57.18M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 57.00M shares.
- 2026-03-11: Entity Common Stock, Shares Outstanding 57.05M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 54.19M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 57.18M shares 10-Q · filed 2026-08-13 |
| 2026-05-08 | 57.00M shares 10-Q · filed 2026-05-13 |
| 2026-03-11 | 57.05M shares 10-K · filed 2026-03-17 |
| 2025-11-07 | 54.19M shares 10-Q · filed 2025-11-12 |
| 2025-08-08 | 51.28M shares 10-Q · filed 2025-08-14 |
| 2025-05-09 | 51.16M shares 10-Q · filed 2025-05-15 |
| 2025-03-11 | 48.53M shares 10-K · filed 2025-03-20 |
| 2024-11-12 | 43.47M shares 10-Q · filed 2024-11-14 |
| 2024-08-02 | 43.31M shares 10-Q · filed 2024-08-12 |
| 2024-05-10 | 41.19M shares 10-Q · filed 2024-05-15 |
| 2024-03-06 | 27.36M shares 10-K · filed 2024-03-18 |
| 2023-11-01 | 24.77M shares 10-Q · filed 2023-11-13 |
| 2023-08-01 | 24.76M shares 10-Q · filed 2023-08-08 |
| 2023-05-04 | 18.78M shares 10-Q · filed 2023-05-11 |
| 2023-03-21 | 17.71M shares 10-K/A · filed 2023-04-10 |
| 2022-11-07 | 17.18M shares 10-Q · filed 2022-11-14 |
| 2022-08-01 | 5.95M shares 10-Q · filed 2022-08-11 |
| 2022-05-03 | 146.95M shares 10-Q · filed 2022-05-13 |
| 2022-03-21 | 147.38M shares 10-K · filed 2022-03-31 |
| 2021-11-08 | 101.92M shares 10-Q · filed 2021-11-15 |
| 2021-07-21 | 101.23M shares 10-Q · filed 2021-07-28 |
| 2021-05-10 | 99.02M shares 10-Q · filed 2021-05-17 |
| 2021-03-19 | 98.79M shares 10-K · filed 2021-03-24 |
| 2020-11-02 | 98.53M shares 10-Q · filed 2020-11-09 |
| 2020-08-03 | 84.78M shares 10-Q · filed 2020-08-10 |
| 2020-05-01 | 83.70M shares 10-Q · filed 2020-05-06 |
| 2020-03-09 | 83.62M shares 10-K · filed 2020-03-16 |
| 2019-11-07 | 51.15M shares 10-Q · filed 2019-11-12 |
| 2019-08-05 | 49.32M shares 10-Q · filed 2019-08-09 |
| 2019-05-06 | 49.16M shares 10-Q · filed 2019-05-10 |
| 2019-03-13 | 47.95M shares 10-K · filed 2019-03-18 |
| 2018-11-09 | 47.94M shares 10-Q · filed 2018-11-09 |
| 2018-08-09 | 47.94M shares 10-Q · filed 2018-08-09 |
| 2018-05-10 | 47.31M shares 10-Q · filed 2018-05-10 |
| 2018-03-15 | 47.23M shares 10-K · filed 2018-03-16 |
| 2017-11-13 | 46.78M shares 10-Q · filed 2017-11-14 |
| 2017-08-11 | 40.29M shares 10-Q · filed 2017-08-14 |
| 2017-05-15 | 40.26M shares 10-Q · filed 2017-05-15 |
| 2017-03-30 | 40.26M shares 10-K · filed 2017-03-30 |
| 2016-11-14 | 39.96M shares 10-Q · filed 2016-11-14 |
| 2016-08-15 | 33.55M shares 10-Q · filed 2016-08-15 |
| 2016-05-16 | 32.80M shares 10-Q · filed 2016-05-16 |
| 2016-03-30 | 32.74M shares 10-K · filed 2016-03-30 |
| 2015-11-16 | 32.73M shares 10-Q · filed 2015-11-16 |
| 2015-08-14 | 32.69M shares 10-Q · filed 2015-08-14 |
| 2015-05-14 | 24.27M shares 10-Q · filed 2015-05-14 |
| 2015-03-30 | 19.99M shares 10-K · filed 2015-03-31 |
| 2012-08-14 | 24.17M shares 10-Q · filed 2012-08-14 |
| 2012-05-15 | 24.16M shares 10-Q · filed 2012-05-15 |
| 2012-03-23 | 20.26M shares 10-K · filed 2012-03-23 |
| 2011-11-11 | 23.17M shares 10-Q · filed 2011-11-14 |
| 2011-08-12 | 11.60M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |